Relapsing-remitting multiple sclerosis and Lipase increased

Summary:

Lipase increased is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 30-39 old.

The study analyzes which people have Lipase increased with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 30 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 127 drugs and 177 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Lipase increased?

Lipase increased is found to be associated with 845 drugs and 1,029 conditions by eHealthMe. Check the latest studies of Lipase increased.

On Jul, 13, 2026

30 people who have Relapsing-Remitting Multiple Sclerosis and Lipase Increased are studied.

Would you have Lipase increased when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Lipase Increased *:

female: 71.43 %
male: 28.57 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Lipase Increased *:

Common co-existing conditions for these people *:

Depression: 5 people, 16.67%
Stress And Anxiety: 4 people, 13.33%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 2 people, 6.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.67%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 6.67%
Urinary Tract Infection: 1 person, 3.33%
Pain: 1 person, 3.33%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 3.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.33%
Asthma: 1 person, 3.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Nausea (feeling of having an urge to vomit): 11 people, 36.67%
Lymphocyte Count Decreased: 9 people, 30.00%
Fatigue (feeling of tiredness): 9 people, 30.00%
Alanine Aminotransferase Increased: 8 people, 26.67%
Haemoglobin Decreased: 7 people, 23.33%
Blood Alkaline Phosphatase Increased: 7 people, 23.33%
Aspartate Aminotransferase Increased: 6 people, 20.00%
Pancreatitis (inflammation of pancreas): 6 people, 20.00%
Abdominal Pain: 6 people, 20.00%
Amylase Increased: 6 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lipase increased?

- Check whether Lipase increased is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Relapsing-remitting multiple sclerosis (76,275 reports)
Lipase increased (11,101 reports)

All the drugs that are associated with Lipase increased:

Lipase increased (845 drugs)

All the conditions that are associated with Lipase increased:

Lipase increased (1,029 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lipase increased and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.